PATENT CLAIM ANALYSIS

Application Number: 15878289
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "249000"]

Abstract:
The invention provides compounds of formula I: and salts thereof, as well as pharmaceutical compositions comprising such compounds. The compounds are useful for treating cancers, Alzheimer's disease, and conditions associated with demyelination.

Claim (Index 12):
The compound of  claim 1  wherein n is 0, 1, or 2.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 86.0
- Lexical Diversity: 1.25806
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15878291', '15878297', '15550230', '14344867', '15112111']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7717358243621272
- 35 USC 102 Novelty (BERT): 0.553701832640715
- Combined Prediction Score: 0.7499324251899859
- Mean Citation Score: 394.216162
- Max Citation Score: 417.4762
- Similarity Product: 279.3241377871752

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test